A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome-Reference-Cited by-同舟云学术

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome

Published:2001-10 Issue:7 Volume:28 Page:643-647
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kröger N,Schetelig J,Zabelina T,Krüger W,Renges H,Stute N,Schrum J,Kabisch H,Siegert W,Zander AR

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703215.pdf

Reference14 articles.

1. Bennett JM, Catovsky D, Daniel MD et al. Proposals for the classification of myelodysplastic syndromes Br J Haematol 1982 51: 189–199

2. Geddes A, Bowen D, Jacobs A . Clonal karyotypic abnormalities and clinical progress in the myelodysplastic syndromes Br J Haematol 1990 76: 194–202

3. De Witte T, Hermans J, Vossen J et al. Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: a report on behalf the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol 2000 110: 620–630

4. Slavin S, Nagler A, Naperstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant diseases Blood 1998 91: 756–763

5. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purin analog-containing chemotherapy: harnessing graft-versus-leukemia effect without myeloablative therapy Blood 1997 89: 4531–4536

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

2. On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2022-01

3. Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan;Bone Marrow Transplantation;2020-03-12

4. Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial;Biology of Blood and Marrow Transplantation;2016-05

5. Optimizing drug therapy in pediatric SCT: Focus on pharmacokinetics;Bone Marrow Transplantation;2014-10-27